Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Annual Report 2002 - Essential Drugs and Medicines Policy: Supporting Countries to Close the Access Gap
(2003; 20 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentDeveloping a monitoring culture to improve impact
View the documentTraditional and complementary medicine: putting policy into action
View the documentKey country support in Africa and Eastern Mediterranean
View the documentWHO Collaborating Centres: supplying active support for medicines work
View the documentHow is TRIPS affecting access to medicines?
View the documentDevelopment of the essential drugs concept over the past 25 years
View the documentMeasuring access to antimalarials
View the documentStrengthening regional and national bulk procurement
View the documentLearning from successful supply systems
View the documentWorking out the cost of medicines
View the documentSupporting MDG target on access to essential medicines
View the documentCommon guideline for evaluating new medicines in Baltic countries
View the documentNGO toolkit for improving access to HIV/AIDS treatment
View the documentHarmonizing medicines regulation in the Americas
View the documentGood manufacturing practice in China: rapid progress
View the documentPharmacovigilance: detecting and reporting adverse drug reactions
View the documentVariations in prescribing information in 26 countries
View the document10th ICDRA: an international basis for medicines regulation
View the documentFighting poor-quality drugs
View the documentImproving medicines use in hospitals in Cambodia and Lao PDR
View the documentWHO-India Essential Drugs Programme: multiplying impact
View the documentOman: improving antibiotic use in primary health care

Common guideline for evaluating new medicines in Baltic countries

Since 1997 WHO has provided sustained medicines support, including courses on pharmaco-economics, assistance for the Baltic Medicines Conferences of 1997 and 2001, and technical input for developing reimbursement systems, to Estonia, Latvia and Lithuania. As a result, these three Baltic countries succeeded in bringing together the expertise and necessary political support for developing and adopting a common guideline on pharmaco-economic evaluation of new medicines. The Ministry of Welfare of the Republic of Latvia, the Ministry of Social Affairs of Estonia and the Ministry of Health of the Republic of Lithuania signed a Memorandum of Understanding in September 2002 agreeing to:

• strengthen co-operation between institutions working on pricing and reimbursement of pharmaceuticals and pharmaco-economic analyses at national level

• use a common methodology for assessing costs and cost-effectiveness of pharmaceuticals in order to support decision-making on resource allocation for health care

• exchange information on prices and pricing of pharmaceuticals

• exchange information on legislative changes relating to pricing and reimbursement of pharmaceuticals, and application of cost-containment measures.

The three countries will now be able to build on each other's assessment of applications for reimbursement, reducing duplication and leading to more informed and consistent decision-making on reimbursement.


to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017